Our teams exercise independent thought with high conviction, resulting in portfolios that we believe are well positioned to address our clients' challenges – all within robust risk control frameworks.

$243.6bn
Equities Assets Under Management

148
Equities Investment
Professionals

19
Average Years’
Experience
As at June 30, 2025
![]() $243.6bn |
![]() 148 |
![]() 19 |
As at June 30, 2025
We measure success by a single factor: client outcomes. As a pure asset manager, our sole mission is to deliver consistent long-term risk-adjusted returns that exceed our benchmarks and peers, regardless of the prevailing investment landscape.
Featured strategies
Equities Strategies
Global/International
- Global Alpha Equity
- Global Research Equity
- Global Research Growth Equity
- Global Small Cap
- International Alpha Equity
- International Research Equity
US
- US Concentrated Growth
- US Mid Cap Growth
- US Mid Cap Value
- US Opportunistic Alpha
- US Research Core Equity
- US Research Growth Equity
- US Small Cap Growth
- US Small Cap Value
- US SMID Cap Growth
- US SMID Cap Value
Specialty
- Biotechnology Innovation
- Global Life Sciences
- Global Property Equities
- Global Sustainable Equity
- Global Technology and Innovation
- U.S. Real Estate Securities
Emerging Markets
Europe
Asia Pacific
Insights
Chart to Watch: Biotech bounces back
Optimism is returning to the biotech space, and we see durable drivers behind the recent performance recovery.
Quick View: Political upheaval and budgetary uncertainty leaves France at a crossroads
Following French Prime Minister François Bayrou’s loss of a confidence vote, Robert-Schramm Fuchs explores the implications for investors and explains why he remains positive on Europe.
Productivity lift: A supportive backdrop for earnings growth
How corporate efficiency is supporting profitability and earnings growth.
Institutional Insights
Sign up to get relevant content delivered straight to your inbox.